__smbhome.uscs.susx.ac.uk_tjk30_Documents_untitled.pdf (851.64 kB)
The impact of diagnostic microbiology on de-escalation of antimicrobial therapy in hospitalised adults
Version 2 2023-06-12, 09:20
Version 1 2023-06-09, 20:24
journal contribution
posted on 2023-06-12, 09:20 authored by William L Hamilton, Sacha-Marie Pires, Samantha Lippett, Vikesh Gudka, Elizabeth L A Cross, Martin LlewelynMartin LlewelynMinimising antimicrobial overuse is needed to limit antimicrobial resistance. There is little evidence on how often microbiological testing informs antimicrobial de-escalation (e.g. stopping, shortening duration, switching to narrower spectrum or intravenous to oral switch) at 48-72 hour “review and revise”. We performed a patient level analysis of diagnostic microbiology and antimicrobial prescribing to determine the impact of microbiology results on antimicrobial review outcomes.
History
Publication status
- Published
File Version
- Published version
Journal
BMC Infectious DiseasesISSN
1471-2334Publisher
BMCExternal DOI
Volume
20Article number
a102Department affiliated with
- Global Health and Infection Publications
Research groups affiliated with
- Brighton and Sussex Centre for Global Health Research Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2020-01-29First Open Access (FOA) Date
2020-02-05First Compliant Deposit (FCD) Date
2020-01-28Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC